Chimerix, Inc.
CMRX
CMRX was delisted on the 17th of April, 2025.
100 hedge funds and large institutions have $178M invested in Chimerix, Inc. in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 15 closing their positions.
992% more call options, than puts
Call options by funds: $2.6M | Put options by funds: $238K
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
6% less funds holding
Funds holding: 106 → 100 (-6)
13% less capital invested
Capital invested by funds: $204M → $178M (-$26.6M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$5.82M |
| 2 |
SC
Sessa Capital
New York
|
+$4.4M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.13M |
| 4 |
Axa
Paris,
France
|
+$1.01M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$679K |
Top Sellers
CMRX Hedge Fund Activity: Q2 2017 in Review
100 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q2 2017, worth a combined $178M — down 13% from $204M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CMRX and 9 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 31 added.
The largest buyer was Morgan Stanley, adding an estimated $5.82M. The largest seller was JP Morgan Chase, cutting an estimated $2.52M.
- 100 institutional investors held Chimerix, Inc. (CMRX) as of Q2 2017, down from 106 in Q1 2017.
- Funds reported $178M of Chimerix, Inc. stock for Q2 2017, down 13% quarter-over-quarter.
- 9 funds opened new Chimerix, Inc. positions in Q2 2017 and 15 closed out, a net change of -6 holders.
- The largest Chimerix, Inc. buyer in Q2 2017 was Morgan Stanley, an estimated $5.82M added.
- The largest Chimerix, Inc. seller in Q2 2017 was JP Morgan Chase, an estimated $2.52M sold.
Based on aggregated 13F filings for Q2 2017.